12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
周一盘中交易时段,12只医疗保健类股走势
Gainers
获胜者
- Bionomics (NASDAQ:BNOX) stock moved upwards by 32.7% to $2.03 during Monday's regular session. Trading volume for Bionomics's stock is 3.0 million as of 13:30 EST. This is 4392.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.5 million.
- XTL Biopharmaceuticals (NASDAQ:XTLB) stock moved upwards by 28.2% to $1.0. The company's market cap stands at $5.4 million.
- Akebia Therapeutics (NASDAQ:AKBA) stock rose 23.35% to $1.42. Akebia Therapeutics's stock is trading at a volume of 3.5 million shares as of 13:30 EST. This is 173.0% of its average full-day volume over the last 100 days. The company's market cap stands at $263.7 million. As per the news, the Q2 earnings report came out yesterday.
- PHAXIAM Therapeutics (NASDAQ:PHXM) stock rose 19.99% to $0.63. The market value of their outstanding shares is at $38.2 million.
- Prenetics Global (NASDAQ:PRE) shares rose 17.76% to $0.54. Trading volume for this security as of 13:30 EST is 202.1K, which is 166.7% of its average full-day volume over the last 100 days. The company's market cap stands at $97.6 million.
- MSP Recovery (NASDAQ:LIFW) stock increased by 17.29% to $0.08. As of 13:30 EST, this security is trading at a volume of 10.6 million shares, making up 1580.1% of its average full-day volume over the last 100 days. The company's market cap stands at $25.9 million.
- 生物学 纳斯达克股票代码:BNOX)股价在周一的例会上涨32.7%,至2.03美元。截至美国东部标准时间 13:30,Bionomics的股票交易量为300万股。这是其过去100天平均全天交易量的4392.4%。他们流通股的市值为1,650万美元。
- XTL 生物制药 纳斯达克股票代码:XTLB)股价上涨28.2%,至1.0美元。该公司的市值为540万美元。
- 阿克比亚疗法 纳斯达克股票代码:AKBA)股价上涨23.35%,至1.42美元。截至美国东部标准时间13点30分,Akebia Therapeutics的股票交易量为350万股。这是其过去100天平均全天交易量的173.0%。该公司的市值为2.637亿美元。消息称,第二季度收益报告已于昨天发布。
- PHAXIAM 治疗药 纳斯达克股票代码:PHXM)股价上涨19.99%,至0.63美元。他们流通股的市值为3,820万美元。
- Prenetics 全球 纳斯达克股票代码:PRE)股价上涨17.76%,至0.54美元。截至美国东部标准时间 13:30,该证券的交易量为20.21万,占其过去100天平均全天交易量的166.7%。该公司的市值为9,760万美元。
- MSP 恢复 纳斯达克股票代码:LIFW)股价上涨17.29%,至0.08美元。截至美国东部标准时间 13:30,该证券的交易量为1,060万股,占其过去100天平均全天交易量的1580.1%。该公司的市值为2590万美元。
Losers
失败者
- NovoCure (NASDAQ:NVCR) stock decreased by 35.1% to $19.33 during Monday's regular session. The current volume of 9.0 million shares is 538.0% of NovoCure's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $2.0 billion.
- Longeveron Inc. - Subscription Right (NASDAQ:LGVNR) shares fell 28.89% to $0.02. The current volume of 195.2K shares is 46.5% of Longeveron Inc. - Subscription Right's average full-day volume over the last 100 days (last updated at 13:30 EST).
- Opthea (NASDAQ:OPT) shares fell 19.82% to $2.59. Trading volume for this security as of 13:30 EST is 91.3K, which is 1157.3% of its average full-day volume over the last 100 days. The company's market cap stands at $151.1 million.
- Aditxt (NASDAQ:ADTX) stock decreased by 16.8% to $7.58. Trading volume for this security as of 13:30 EST is 60.9K, which is 84.1% of its average full-day volume over the last 100 days. The company's market cap stands at $1.4 million.
- SAB Biotherapeutics (NASDAQ:SABS) stock decreased by 16.42% to $0.56. The market value of their outstanding shares is at $29.2 million.
- Novo Integrated Sciences (NASDAQ:NVOS) stock decreased by 13.87% to $0.15. The current volume of 20.7 million shares is 87.3% of Novo Integrated Sciences's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $21.8 million. See Also:
- NovoCure 纳斯达克股票代码:NVCR)股价在周一的例会上下跌35.1%,至19.33美元。目前的900万股成交量占NovoCure过去100天平均全天成交量的538.0%(最后更新时间为美国东部标准时间 13:30)。他们流通股的市值为20亿美元。
- Longeveron Inc.-订阅权 纳斯达克股票代码:LGVNR)股价下跌28.89%,至0.02美元。目前的19.52万股成交量为Longeveron Inc.——Subscription Right在过去100天内平均全天交易量的46.5%(最后更新时间为美国东部标准时间13点30分)。
- Opthea 纳斯达克股票代码:OPT)股价下跌19.82%,至2.59美元。截至美国东部标准时间 13:30,该证券的交易量为91.3万,占其过去100天平均全天交易量的1157.3%。该公司的市值为1.511亿美元。
- aditxt 纳斯达克股票代码:ADTX)股价下跌16.8%,至7.58美元。截至美国东部标准时间 13:30,该证券的交易量为60.9万,占其过去100天平均全天交易量的84.1%。该公司的市值为140万美元。
- SAB 生物疗法 纳斯达克股票代码:SABS)股价下跌16.42%,至0.56美元。他们流通股的市值为2920万美元。
- Novo 综合科学 纳斯达克股票代码:NVOS)股价下跌13.87%,至0.15美元。目前的2,070万股成交量占Novo Integrated Sciences过去100天平均全天成交量的87.3%(最后更新时间为美国东部标准时间13点30分)。该公司的市值为2180万美元。 另请参阅:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。